Skip to content
★ Sign in to follow
DD
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€86k
▼ Sales (0 ops.)
—

Latest filing published 01 May 2015 for Catalyst Pharmaceuticals, INC., €4,851.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David D. Muth: trading record in brief

David D. Muth is a declared insider of Catalyst Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 3 October 2014 to 1 May 2015.

Every open-market trade on record is a purchase: 5 purchases worth €86k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2015, the count stands at 4 purchases and no sales.

In size, the median ticket on the buying side is €5,502.

The record was last updated on 1 May 2015 with an open-market purchase (€4,851) in Catalyst Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David D. Muth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    EVP, Chief Commercial OfficerExecutivesCatalyst Pharmaceuticals, Inc.
    5,440 USD0SEC
    1,700 shares@ US$3.20Common Stock, par value $0.001 per shareSEC:0001161697-15-000205:0
    Canonical exit: 30 Jul 2015 (T+90)
  • ▲
    EVP, Chief Commercial OfficerExecutivesCatalyst Pharmaceuticals, Inc.
    6,035 USD0SEC
    1,700 shares@ US$3.55Common Stock, par value $0.001 per shareSEC:0001161697-15-000201:0
    Canonical exit: 27 Jul 2015 (T+90)
  • ▲
    EVP, Chief Commercial OfficerExecutivesCatalyst Pharmaceuticals, Inc.
    1,065 USD0SEC
    300 shares@ US$3.55Common Stock, par value $0.001 per shareSEC:0001161697-15-000201:1
    Canonical exit: 27 Jul 2015 (T+90)
  • ▲
    EVP, Chief Commercial OfficerExecutivesCatalyst Pharmaceuticals, Inc.
    62,160 USD0SEC
    21,000 shares@ US$2.96Common Stock, par value $0.001 per shareSEC:0001161697-15-000039:0
    Canonical exit: 20 Apr 2015 (T+90)
  • ▲
    Exec. V.P., Corp. DevelopmentExecutivesCatalyst Pharmaceuticals, Inc.
    26,500 USD0SEC
    10,000 shares@ US$2.65Common Stock, par value $0.001 per shareSEC:0001161697-14-000498:0
    Canonical exit: 1 Jan 2015 (T+90)

5 of 5 declarations